ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psychedelic Medicine Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-1S10196
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Psychedelic Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Global Psychedelic Medicine Market Research Report 2025

Code: QYRE-Auto-1S10196
Report
June 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
COMPASS Pathways PLC
Pfizer Inc
Eli Lilly
GlaxoSmithKline PLC
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
ACADIA Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical

Psychedelic Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psychedelic Medicine Market

Psychedelic Medicine Market

The global market for Psychedelic Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psychedelic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychedelic Medicine.
The Psychedelic Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psychedelic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psychedelic Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Psychedelic Medicine Market Report

Report Metric Details
Report Name Psychedelic Medicine Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS, MindMed, HAVN Life Sciences, Seelos Therapeutics, Jannsen, Acadia Pharmaceuticals, Intellipharmaceutics, Revive Therapeutics, Mydecine Innovations Group, Red Light Holland, Braxia Scientific, Mind Cure Health, Entheon Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Psychedelic Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psychedelic Medicine Market report?

Ans: The main players in the Psychedelic Medicine Market are COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS, MindMed, HAVN Life Sciences, Seelos Therapeutics, Jannsen, Acadia Pharmaceuticals, Intellipharmaceutics, Revive Therapeutics, Mydecine Innovations Group, Red Light Holland, Braxia Scientific, Mind Cure Health, Entheon Biomedical

What are the Application segmentation covered in the Psychedelic Medicine Market report?

Ans: The Applications covered in the Psychedelic Medicine Market report are Depressive Disorders, Post-Traumatic Stress Disorders, Substance Abuse Disorders, Obsessive Compulsive Disorders, Others

What are the Type segmentation covered in the Psychedelic Medicine Market report?

Ans: The Types covered in the Psychedelic Medicine Market report are Psilocybin, LSD, MDMA, DMT, Ketamine, Others

Recommended Reports

Mental Health Therapies

Pharmaceutical Drug Markets

Alternative Medicines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychedelic Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Psilocybin
1.2.3 LSD
1.2.4 MDMA
1.2.5 DMT
1.2.6 Ketamine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Psychedelic Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Depressive Disorders
1.3.3 Post-Traumatic Stress Disorders
1.3.4 Substance Abuse Disorders
1.3.5 Obsessive Compulsive Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psychedelic Medicine Market Perspective (2020-2031)
2.2 Global Psychedelic Medicine Growth Trends by Region
2.2.1 Global Psychedelic Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psychedelic Medicine Historic Market Size by Region (2020-2025)
2.2.3 Psychedelic Medicine Forecasted Market Size by Region (2026-2031)
2.3 Psychedelic Medicine Market Dynamics
2.3.1 Psychedelic Medicine Industry Trends
2.3.2 Psychedelic Medicine Market Drivers
2.3.3 Psychedelic Medicine Market Challenges
2.3.4 Psychedelic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychedelic Medicine Players by Revenue
3.1.1 Global Top Psychedelic Medicine Players by Revenue (2020-2025)
3.1.2 Global Psychedelic Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Psychedelic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psychedelic Medicine Revenue
3.4 Global Psychedelic Medicine Market Concentration Ratio
3.4.1 Global Psychedelic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychedelic Medicine Revenue in 2024
3.5 Global Key Players of Psychedelic Medicine Head office and Area Served
3.6 Global Key Players of Psychedelic Medicine, Product and Application
3.7 Global Key Players of Psychedelic Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychedelic Medicine Breakdown Data by Type
4.1 Global Psychedelic Medicine Historic Market Size by Type (2020-2025)
4.2 Global Psychedelic Medicine Forecasted Market Size by Type (2026-2031)
5 Psychedelic Medicine Breakdown Data by Application
5.1 Global Psychedelic Medicine Historic Market Size by Application (2020-2025)
5.2 Global Psychedelic Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psychedelic Medicine Market Size (2020-2031)
6.2 North America Psychedelic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psychedelic Medicine Market Size by Country (2020-2025)
6.4 North America Psychedelic Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psychedelic Medicine Market Size (2020-2031)
7.2 Europe Psychedelic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psychedelic Medicine Market Size by Country (2020-2025)
7.4 Europe Psychedelic Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psychedelic Medicine Market Size (2020-2031)
8.2 Asia-Pacific Psychedelic Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psychedelic Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Psychedelic Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psychedelic Medicine Market Size (2020-2031)
9.2 Latin America Psychedelic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psychedelic Medicine Market Size by Country (2020-2025)
9.4 Latin America Psychedelic Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychedelic Medicine Market Size (2020-2031)
10.2 Middle East & Africa Psychedelic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psychedelic Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Psychedelic Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Details
11.1.2 COMPASS Pathways PLC Business Overview
11.1.3 COMPASS Pathways PLC Psychedelic Medicine Introduction
11.1.4 COMPASS Pathways PLC Revenue in Psychedelic Medicine Business (2020-2025)
11.1.5 COMPASS Pathways PLC Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Psychedelic Medicine Introduction
11.2.4 Pfizer Revenue in Psychedelic Medicine Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Psychedelic Medicine Introduction
11.3.4 Eli Lilly Revenue in Psychedelic Medicine Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Psychedelic Medicine Introduction
11.4.4 GlaxoSmithKline Revenue in Psychedelic Medicine Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Cybin Inc
11.5.1 Cybin Inc Company Details
11.5.2 Cybin Inc Business Overview
11.5.3 Cybin Inc Psychedelic Medicine Introduction
11.5.4 Cybin Inc Revenue in Psychedelic Medicine Business (2020-2025)
11.5.5 Cybin Inc Recent Development
11.6 Field Trip Health
11.6.1 Field Trip Health Company Details
11.6.2 Field Trip Health Business Overview
11.6.3 Field Trip Health Psychedelic Medicine Introduction
11.6.4 Field Trip Health Revenue in Psychedelic Medicine Business (2020-2025)
11.6.5 Field Trip Health Recent Development
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Details
11.7.2 ATAI Life Sciences Business Overview
11.7.3 ATAI Life Sciences Psychedelic Medicine Introduction
11.7.4 ATAI Life Sciences Revenue in Psychedelic Medicine Business (2020-2025)
11.7.5 ATAI Life Sciences Recent Development
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Details
11.8.2 NUMINUS WELLNESS Business Overview
11.8.3 NUMINUS WELLNESS Psychedelic Medicine Introduction
11.8.4 NUMINUS WELLNESS Revenue in Psychedelic Medicine Business (2020-2025)
11.8.5 NUMINUS WELLNESS Recent Development
11.9 MindMed
11.9.1 MindMed Company Details
11.9.2 MindMed Business Overview
11.9.3 MindMed Psychedelic Medicine Introduction
11.9.4 MindMed Revenue in Psychedelic Medicine Business (2020-2025)
11.9.5 MindMed Recent Development
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Details
11.10.2 HAVN Life Sciences Business Overview
11.10.3 HAVN Life Sciences Psychedelic Medicine Introduction
11.10.4 HAVN Life Sciences Revenue in Psychedelic Medicine Business (2020-2025)
11.10.5 HAVN Life Sciences Recent Development
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Details
11.11.2 Seelos Therapeutics Business Overview
11.11.3 Seelos Therapeutics Psychedelic Medicine Introduction
11.11.4 Seelos Therapeutics Revenue in Psychedelic Medicine Business (2020-2025)
11.11.5 Seelos Therapeutics Recent Development
11.12 Jannsen
11.12.1 Jannsen Company Details
11.12.2 Jannsen Business Overview
11.12.3 Jannsen Psychedelic Medicine Introduction
11.12.4 Jannsen Revenue in Psychedelic Medicine Business (2020-2025)
11.12.5 Jannsen Recent Development
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Details
11.13.2 Acadia Pharmaceuticals Business Overview
11.13.3 Acadia Pharmaceuticals Psychedelic Medicine Introduction
11.13.4 Acadia Pharmaceuticals Revenue in Psychedelic Medicine Business (2020-2025)
11.13.5 Acadia Pharmaceuticals Recent Development
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Details
11.14.2 Intellipharmaceutics Business Overview
11.14.3 Intellipharmaceutics Psychedelic Medicine Introduction
11.14.4 Intellipharmaceutics Revenue in Psychedelic Medicine Business (2020-2025)
11.14.5 Intellipharmaceutics Recent Development
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Details
11.15.2 Revive Therapeutics Business Overview
11.15.3 Revive Therapeutics Psychedelic Medicine Introduction
11.15.4 Revive Therapeutics Revenue in Psychedelic Medicine Business (2020-2025)
11.15.5 Revive Therapeutics Recent Development
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Details
11.16.2 Mydecine Innovations Group Business Overview
11.16.3 Mydecine Innovations Group Psychedelic Medicine Introduction
11.16.4 Mydecine Innovations Group Revenue in Psychedelic Medicine Business (2020-2025)
11.16.5 Mydecine Innovations Group Recent Development
11.17 Red Light Holland
11.17.1 Red Light Holland Company Details
11.17.2 Red Light Holland Business Overview
11.17.3 Red Light Holland Psychedelic Medicine Introduction
11.17.4 Red Light Holland Revenue in Psychedelic Medicine Business (2020-2025)
11.17.5 Red Light Holland Recent Development
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Details
11.18.2 Braxia Scientific Business Overview
11.18.3 Braxia Scientific Psychedelic Medicine Introduction
11.18.4 Braxia Scientific Revenue in Psychedelic Medicine Business (2020-2025)
11.18.5 Braxia Scientific Recent Development
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Details
11.19.2 Mind Cure Health Business Overview
11.19.3 Mind Cure Health Psychedelic Medicine Introduction
11.19.4 Mind Cure Health Revenue in Psychedelic Medicine Business (2020-2025)
11.19.5 Mind Cure Health Recent Development
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Details
11.20.2 Entheon Biomedical Business Overview
11.20.3 Entheon Biomedical Psychedelic Medicine Introduction
11.20.4 Entheon Biomedical Revenue in Psychedelic Medicine Business (2020-2025)
11.20.5 Entheon Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
COMPASS Pathways PLC
Pfizer Inc
Eli Lilly
GlaxoSmithKline PLC
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
ACADIA Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
List of Tables
 Table 1. Global Psychedelic Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Psilocybin
 Table 3. Key Players of LSD
 Table 4. Key Players of MDMA
 Table 5. Key Players of DMT
 Table 6. Key Players of Ketamine
 Table 7. Key Players of Others
 Table 8. Global Psychedelic Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Psychedelic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Psychedelic Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Psychedelic Medicine Market Share by Region (2020-2025)
 Table 12. Global Psychedelic Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Psychedelic Medicine Market Share by Region (2026-2031)
 Table 14. Psychedelic Medicine Market Trends
 Table 15. Psychedelic Medicine Market Drivers
 Table 16. Psychedelic Medicine Market Challenges
 Table 17. Psychedelic Medicine Market Restraints
 Table 18. Global Psychedelic Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Psychedelic Medicine Market Share by Players (2020-2025)
 Table 20. Global Top Psychedelic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychedelic Medicine as of 2024)
 Table 21. Ranking of Global Top Psychedelic Medicine Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Psychedelic Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Psychedelic Medicine, Headquarters and Area Served
 Table 24. Global Key Players of Psychedelic Medicine, Product and Application
 Table 25. Global Key Players of Psychedelic Medicine, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Psychedelic Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Psychedelic Medicine Revenue Market Share by Type (2020-2025)
 Table 29. Global Psychedelic Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Psychedelic Medicine Revenue Market Share by Type (2026-2031)
 Table 31. Global Psychedelic Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Psychedelic Medicine Revenue Market Share by Application (2020-2025)
 Table 33. Global Psychedelic Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Psychedelic Medicine Revenue Market Share by Application (2026-2031)
 Table 35. North America Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Psychedelic Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Psychedelic Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Psychedelic Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Psychedelic Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Psychedelic Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Psychedelic Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Psychedelic Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Psychedelic Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Psychedelic Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Psychedelic Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Psychedelic Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 50. COMPASS Pathways PLC Company Details
 Table 51. COMPASS Pathways PLC Business Overview
 Table 52. COMPASS Pathways PLC Psychedelic Medicine Product
 Table 53. COMPASS Pathways PLC Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 54. COMPASS Pathways PLC Recent Development
 Table 55. Pfizer Company Details
 Table 56. Pfizer Business Overview
 Table 57. Pfizer Psychedelic Medicine Product
 Table 58. Pfizer Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 59. Pfizer Recent Development
 Table 60. Eli Lilly Company Details
 Table 61. Eli Lilly Business Overview
 Table 62. Eli Lilly Psychedelic Medicine Product
 Table 63. Eli Lilly Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 64. Eli Lilly Recent Development
 Table 65. GlaxoSmithKline Company Details
 Table 66. GlaxoSmithKline Business Overview
 Table 67. GlaxoSmithKline Psychedelic Medicine Product
 Table 68. GlaxoSmithKline Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 69. GlaxoSmithKline Recent Development
 Table 70. Cybin Inc Company Details
 Table 71. Cybin Inc Business Overview
 Table 72. Cybin Inc Psychedelic Medicine Product
 Table 73. Cybin Inc Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 74. Cybin Inc Recent Development
 Table 75. Field Trip Health Company Details
 Table 76. Field Trip Health Business Overview
 Table 77. Field Trip Health Psychedelic Medicine Product
 Table 78. Field Trip Health Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 79. Field Trip Health Recent Development
 Table 80. ATAI Life Sciences Company Details
 Table 81. ATAI Life Sciences Business Overview
 Table 82. ATAI Life Sciences Psychedelic Medicine Product
 Table 83. ATAI Life Sciences Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 84. ATAI Life Sciences Recent Development
 Table 85. NUMINUS WELLNESS Company Details
 Table 86. NUMINUS WELLNESS Business Overview
 Table 87. NUMINUS WELLNESS Psychedelic Medicine Product
 Table 88. NUMINUS WELLNESS Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 89. NUMINUS WELLNESS Recent Development
 Table 90. MindMed Company Details
 Table 91. MindMed Business Overview
 Table 92. MindMed Psychedelic Medicine Product
 Table 93. MindMed Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 94. MindMed Recent Development
 Table 95. HAVN Life Sciences Company Details
 Table 96. HAVN Life Sciences Business Overview
 Table 97. HAVN Life Sciences Psychedelic Medicine Product
 Table 98. HAVN Life Sciences Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 99. HAVN Life Sciences Recent Development
 Table 100. Seelos Therapeutics Company Details
 Table 101. Seelos Therapeutics Business Overview
 Table 102. Seelos Therapeutics Psychedelic Medicine Product
 Table 103. Seelos Therapeutics Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 104. Seelos Therapeutics Recent Development
 Table 105. Jannsen Company Details
 Table 106. Jannsen Business Overview
 Table 107. Jannsen Psychedelic Medicine Product
 Table 108. Jannsen Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 109. Jannsen Recent Development
 Table 110. Acadia Pharmaceuticals Company Details
 Table 111. Acadia Pharmaceuticals Business Overview
 Table 112. Acadia Pharmaceuticals Psychedelic Medicine Product
 Table 113. Acadia Pharmaceuticals Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 114. Acadia Pharmaceuticals Recent Development
 Table 115. Intellipharmaceutics Company Details
 Table 116. Intellipharmaceutics Business Overview
 Table 117. Intellipharmaceutics Psychedelic Medicine Product
 Table 118. Intellipharmaceutics Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 119. Intellipharmaceutics Recent Development
 Table 120. Revive Therapeutics Company Details
 Table 121. Revive Therapeutics Business Overview
 Table 122. Revive Therapeutics Psychedelic Medicine Product
 Table 123. Revive Therapeutics Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 124. Revive Therapeutics Recent Development
 Table 125. Mydecine Innovations Group Company Details
 Table 126. Mydecine Innovations Group Business Overview
 Table 127. Mydecine Innovations Group Psychedelic Medicine Product
 Table 128. Mydecine Innovations Group Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 129. Mydecine Innovations Group Recent Development
 Table 130. Red Light Holland Company Details
 Table 131. Red Light Holland Business Overview
 Table 132. Red Light Holland Psychedelic Medicine Product
 Table 133. Red Light Holland Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 134. Red Light Holland Recent Development
 Table 135. Braxia Scientific Company Details
 Table 136. Braxia Scientific Business Overview
 Table 137. Braxia Scientific Psychedelic Medicine Product
 Table 138. Braxia Scientific Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 139. Braxia Scientific Recent Development
 Table 140. Mind Cure Health Company Details
 Table 141. Mind Cure Health Business Overview
 Table 142. Mind Cure Health Psychedelic Medicine Product
 Table 143. Mind Cure Health Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 144. Mind Cure Health Recent Development
 Table 145. Entheon Biomedical Company Details
 Table 146. Entheon Biomedical Business Overview
 Table 147. Entheon Biomedical Psychedelic Medicine Product
 Table 148. Entheon Biomedical Revenue in Psychedelic Medicine Business (2020-2025) & (US$ Million)
 Table 149. Entheon Biomedical Recent Development
 Table 150. Research Programs/Design for This Report
 Table 151. Key Data Information from Secondary Sources
 Table 152. Key Data Information from Primary Sources
 Table 153. Authors List of This Report


List of Figures
 Figure 1. Psychedelic Medicine Picture
 Figure 2. Global Psychedelic Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Psychedelic Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Psilocybin Features
 Figure 5. LSD Features
 Figure 6. MDMA Features
 Figure 7. DMT Features
 Figure 8. Ketamine Features
 Figure 9. Others Features
 Figure 10. Global Psychedelic Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Psychedelic Medicine Market Share by Application: 2024 VS 2031
 Figure 12. Depressive Disorders Case Studies
 Figure 13. Post-Traumatic Stress Disorders Case Studies
 Figure 14. Substance Abuse Disorders Case Studies
 Figure 15. Obsessive Compulsive Disorders Case Studies
 Figure 16. Others Case Studies
 Figure 17. Psychedelic Medicine Report Years Considered
 Figure 18. Global Psychedelic Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Psychedelic Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Psychedelic Medicine Market Share by Region: 2024 VS 2031
 Figure 21. Global Psychedelic Medicine Market Share by Players in 2024
 Figure 22. Global Top Psychedelic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychedelic Medicine as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Psychedelic Medicine Revenue in 2024
 Figure 24. North America Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Psychedelic Medicine Market Share by Country (2020-2031)
 Figure 26. United States Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Psychedelic Medicine Market Share by Country (2020-2031)
 Figure 30. Germany Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Psychedelic Medicine Market Share by Region (2020-2031)
 Figure 38. China Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Psychedelic Medicine Market Share by Country (2020-2031)
 Figure 46. Mexico Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Psychedelic Medicine Market Share by Country (2020-2031)
 Figure 50. Turkey Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Psychedelic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. COMPASS Pathways PLC Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 54. Pfizer Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 55. Eli Lilly Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 56. GlaxoSmithKline Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 57. Cybin Inc Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 58. Field Trip Health Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 59. ATAI Life Sciences Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 60. NUMINUS WELLNESS Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 61. MindMed Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 62. HAVN Life Sciences Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 63. Seelos Therapeutics Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 64. Jannsen Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 65. Acadia Pharmaceuticals Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 66. Intellipharmaceutics Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 67. Revive Therapeutics Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 68. Mydecine Innovations Group Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 69. Red Light Holland Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 70. Braxia Scientific Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 71. Mind Cure Health Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 72. Entheon Biomedical Revenue Growth Rate in Psychedelic Medicine Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Psilocybin Assisted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Magic Mushroom Psilocybin Market Research Report 2024
Depression Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Placebo Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Cannabis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression MDD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Legal Recreational Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ayurvedic Herbs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anxiety and Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Free Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anxiety Disorders And Depression Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insomnia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insomnia Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidepressant Medication Market Research Report 2025
Image Guided Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions